$KOPN
KOPIN CORP Stock $kopn

$kopn Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040304 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2022 Q3
Revenue	$8.578M	$13.38M
YoY Change	-29.6%	22.88%
Cost Of Revenue	$7.193M	$7.987M
YoY Change	-19.02%	55.24%
Gross Profit	$1.384M	$5.391M
YoY Change	-58.07%	-6.12%
Gross Profit Margin	16.14%	40.3%
Selling, General & Admin	$5.929M	$4.320M
YoY Change	22.18%	7.04%
% of Gross Profit	428.32%	80.14%
Research & Development	$2.243M	$3.441M
YoY Change	-52.0%	-8.27%
% of Gross Profit	162.01%	63.84%
Depreciation & Amortization	$108.2K	$130.0K
YoY Change	90.53%	-15.64%
% of Gross Profit	7.82%	2.41%
Operating Expenses	$8.172M	$7.762M
YoY Change	-14.21%	-0.34%
Operating Profit	-$6.788M	-$2.371M
YoY Change	9.07%	15.88%
Interest Expense	$196.9K	-$2.091M
YoY Change	-426.43%	10659.91%
% of Operating Profit
Other Income/Expense, Net	$140.8K	-$2.094M
YoY Change	-13.23%	6540.91%
Pretax Income	-$6.450M	-$4.465M
YoY Change	5.37%	112.93%
Income Tax	$39.00K	$36.00K
% Of Pretax Income
Net Earnings	-$6.489M	-$4.501M
YoY Change	5.39%	111.41%
Net Earnings / Revenue	-75.65%	-33.64%
Basic Earnings Per Share		-$0.07
Diluted Earnings Per Share	-$0.06	-$48.13K
COMMON SHARES
Basic Shares Outstanding	114.4M shares	93.64M shares
Diluted Shares Outstanding		93.52M shares

Balance Sheet

Concept	2023 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.40M	$14.97M
YoY Change	37.6%	-52.87%
Cash & Equivalents	$5.711M	$14.97M
Short-Term Investments	$11.69M	$5.378M
Other Short-Term Assets	$1.710M	$1.760M
YoY Change	44.89%	-12.01%
Inventory	$7.602M	$6.661M
Prepaid Expenses
Receivables	$13.12M	$14.79M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$39.83M	$38.18M
YoY Change	29.07%	-24.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.668M	$5.168M
YoY Change	154.87%	44.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.689M	$7.612M
YoY Change	-39.28%	66.94%
Other Assets	$124.9K	$170.9K
YoY Change	-26.57%	0.0%
Total Long-Term Assets	$9.482M	$12.95M
YoY Change	-26.45%	55.93%
TOTAL ASSETS
Total Short-Term Assets	$39.83M	$38.18M
Total Long-Term Assets	$9.482M	$12.95M
Total Assets	$49.31M	$51.13M
YoY Change	12.71%	-13.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.077M	$4.937M
YoY Change	30.11%	35.79%
Accrued Expenses	$6.216M	$8.283M
YoY Change	-8.79%	35.49%
Deferred Revenue	$916.8K	$1.098M
YoY Change	-1.47%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.88M	$15.12M
YoY Change	9.83%	10.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.925M	$4.149M
YoY Change	186.55%	73.96%
Total Long-Term Liabilities	$3.925M	$4.149M
YoY Change	186.55%	73.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.88M	$15.12M
Total Long-Term Liabilities	$3.925M	$4.149M
Total Liabilities	$19.80M	$19.10M
YoY Change	0.21%	20.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$358.2M	-$332.2M
YoY Change	5.84%
Common Stock	$1.123M	$926.3K
YoY Change	20.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$103.1K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$29.51M	$32.03M
YoY Change
Total Liabilities & Shareholders Equity	$49.31M	$51.13M
YoY Change	12.71%	-13.27%

Cashflow Statement

Concept	2023 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$6.489M	-$4.501M
YoY Change	5.39%	111.41%
Depreciation, Depletion And Amortization	$108.2K	$130.0K
YoY Change	90.53%	-15.64%
Cash From Operating Activities	-$3.471M	-$4.166M
YoY Change	66.5%	20.62%
INVESTING ACTIVITIES
Capital Expenditures	$469.5K	-$37.21K
YoY Change	146.37%	-80.6%
Acquisitions
YoY Change
Other Investing Activities	$52.51K	-$480.6K
YoY Change	-94.73%	1599.86%
Cash From Investing Activities	-$427.0K	-$517.7K
YoY Change	-152.94%	135.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-5.000K	832.2K
YoY Change	-95.15%	-82.26%
NET CHANGE
Cash From Operating Activities	-3.471M	-4.166M
Cash From Investing Activities	-427.0K	-517.7K
Cash From Financing Activities	-5.000K	832.2K
Net Change In Cash	-3.903M	-3.851M
YoY Change	182.58%	-478.62%
FREE CASH FLOW
Cash From Operating Activities	-$3.471M	-$4.166M
Capital Expenditures	$469.5K	-$37.21K
Free Cash Flow	-$3.940M	-$4.128M
YoY Change	73.19%	26.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax		usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
	dei	Entity Central Index Key EntityCentralIndexKey	0000771266
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022Q4	us-gaap	Deposits Deposits		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax		usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q2	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization		usd
	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi		usd
	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock		usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation		usd
CY2022Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty		usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty		usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent		usd
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-19882
	dei	Entity Registrant Name EntityRegistrantName	KOPIN CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2833935
	dei	Entity Address Address Line1 EntityAddressAddressLine1	125 North Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Westborough
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01581-3335
	dei	City Area Code CityAreaCode	(508)
	dei	Local Phone Number LocalPhoneNumber	870-5959
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01
	dei	Trading Symbol TradingSymbol	KOPN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	114449134	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9599675	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8258878	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	11610485	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4388778	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1025000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	303000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7118214	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6537891	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5882340	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4068364	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	9074492	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6426400	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	104671	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	105495	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1478375	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1074867	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	45368252	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	30860673	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1794832	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1831641	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2670116	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3168520	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	169132	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	170132	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4603014	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	7721206	usd
CY2023Q3	us-gaap	Assets Assets	54605346	usd
CY2022Q4	us-gaap	Assets Assets	43752172	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7187025	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5438980	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1717584	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2879139	usd
CY2023Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2161000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1966000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	668046	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	930500	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	762521	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	786928	usd
CY2023Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	790000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	790000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1765544	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1182346	usd
CY2023Q3	us-gaap	Deposits Deposits	559503	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	450480	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	482739	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	16061703	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14456632	usd
CY2023Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	267226	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	248284	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2008077	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2576883	usd
CY2023Q3	KOPN	Accrued Postretirement Benefits Net Of Current Portion AccruedPostretirementBenefitsNetOfCurrentPortion	507496	usd
CY2022Q4	KOPN	Accrued Postretirement Benefits Net Of Current Portion AccruedPostretirementBenefitsNetOfCurrentPortion	1110000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1391121	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1369758	usd
CY2023Q3	us-gaap	Liabilities Liabilities	20235623	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19761557	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	114415269	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94920060	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110396217	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92883524	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	1104668	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	929540	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	383898603	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	360567631	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	70635	shares
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	70635	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	103127	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	103127	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1135641	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1176068	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-351666062	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-338406815	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	34369723	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24163297	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-172682	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34369723	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23990615	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54605346	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43752172	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10598497	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11729379	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31816544	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35216833	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5437953	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7987154	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	17759117	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	23676283	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3089935	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3441405	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8534411	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13995393	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4798598	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4320117	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15912848	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13112133	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	13326486	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	15748676	usd
	us-gaap	Operating Expenses OperatingExpenses	42206376	usd
	us-gaap	Operating Expenses OperatingExpenses	50783809	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2727989	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4019297	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10389832	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15566976	usd
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	299506	usd
CY2022Q3	us-gaap	Interest Income Operating InterestIncomeOperating	21663	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	623971	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	41195	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	31608	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3225	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	104403	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7952	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2000000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3327347	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2700000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-14438	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-112315	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-153442	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-227294	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	316676	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2093877	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2752415	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2505949	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2411313	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6113174	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13142247	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13061027	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	108000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2450313	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-6149174	usd
	us-gaap	Profit Loss ProfitLoss	-13259247	usd
	us-gaap	Profit Loss ProfitLoss	-13169027	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-280	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2450313	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-6149174	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13259247	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13168747	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110360814	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110360814	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93516231	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93516231	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108436146	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108436146	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91317288	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91317288	shares
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-2450313	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-6149174	usd
	us-gaap	Profit Loss ProfitLoss	-13259247	usd
	us-gaap	Profit Loss ProfitLoss	-13169027	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-10229	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-128994	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	31955	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-170349	usd
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-54175	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.55
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-34110	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-72382	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-212889	usd
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	522	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-64404	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-163104	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-40427	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-383760	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2514717	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6312278	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13299674	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13552787	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-280	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2514717	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6312278	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13299674	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13552507	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23990615	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	194190	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6227	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	21335000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-2628555	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42897477	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1191257	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	17750	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-8180379	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35926105	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34369723	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	39626857	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	656073	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113906	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	95613	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1372664	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38700747	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	417033	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-106750	usd
CY2022Q2	KOPN	Stock Issued During Period Value Sale Of Registered Stock StockIssuedDuringPeriodValueSaleOfRegisteredStock	2027105	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-5647189	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	35390946	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	297549	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-163104	usd
CY2022Q3	KOPN	Stock Issued During Period Value Sale Of Registered Stock StockIssuedDuringPeriodValueSaleOfRegisteredStock	832236	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-6149174	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30208453	usd
	us-gaap	Profit Loss ProfitLoss	-13259247	usd
	us-gaap	Profit Loss ProfitLoss	-13169027	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	498188	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	665217	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	128	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2343782	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1370654	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-27478	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-339186	usd
	KOPN	Change In Allowance For Doubtful Accounts Receivable ChangeInAllowanceForDoubtfulAccountsReceivable	-726413	usd
	KOPN	Change In Allowance For Doubtful Accounts Receivable ChangeInAllowanceForDoubtfulAccountsReceivable	-4772	usd
	us-gaap	Inventory Write Down InventoryWriteDown	292405	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1670993	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2887893	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2700000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-18878	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-202670	usd
	KOPN	Gain Loss On Income Taxes GainLossOnIncomeTaxes	-117316	usd
	KOPN	Gain Loss On Income Taxes GainLossOnIncomeTaxes	-107509	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-194890	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1451478	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2137460	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3756182	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1651437	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	2302972	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2944672	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1944577	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	461365	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	272446	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1799444	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1651538	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-244188	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3130965	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11791682	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15602736	usd
	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	14656	usd
	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	23802	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	478282	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	642146	usd
	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	499998	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	10374593	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1000000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	17624779	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4000042	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7713812	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4118384	usd
	us-gaap	Proceeds From Sale Of Treasury Stock ProceedsFromSaleOfTreasuryStock	461723	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21335000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2397618	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	95613	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21335000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2763728	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11291	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-205125	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1840797	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17162517	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8258878	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26787931	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10099675	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9625414	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_804_eus-gaap--BasisOfAccounting_zl9aetjPyD35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_820_zi8ZrPRindmd">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements of Kopin Corporation as of September 30, 2023 and for the nine month periods ended September 30, 2023 and September 24, 2022 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements for the nine months ended September 30, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. The condensed consolidated financial statements for the nine months ended September 24, 2022 include the accounts of Kopin Corporation and its wholly owned subsidiaries. Net loss attributable to noncontrolling interest in the Company’s condensed consolidated statements of operations for the nine months ended September 24, 2022 represents the <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20220924__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EMDTMember_zPglYuEz91Ji" title="Equity ownership percentage">20</span>% of the results of operations of a former partially owned subsidiary which is allocated to the shareholders of the equity interests not owned by the Company. All intercompany transactions and balances have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s current strategy is to continue to invest in research and development, even during unprofitable periods, which may result in the Company continuing to incur net losses and negative cash flows from operations. If the Company is unable to achieve and maintain positive cash flows and profitability in the foreseeable future, its financial condition may ultimately be materially adversely affected such that management may be required to reduce operating expenses, including investments in research and development, or raise additional capital. While there can be no assurance the Company will be able to successfully reduce operating expenses or raise additional capital, management believes its historical success in managing cash flows and obtaining capital will continue in the foreseeable future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 27, 2023, the Company sold <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230126__20230127_zhtBjeQ37ihb" title="Number of registered common stock sold">17,000,000</span> shares of common stock and pre-funded warrants to purchase up to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230127__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_z1rpBzSmKP35" title="Pre-funded warrants issued to purchase common stock">6,000,000</span> shares of common stock at a public offering price of $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20230127__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_zJPPxGR04mE9" title="Offering price per share">0.99</span> per share for net proceeds of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfWarrants_pn5n6_c20230126__20230127__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_z5qprbdBs9Qc" title="Proceeds from issuance of warrants">21.4</span> million. The Company believes that its existing cash and cash equivalents will be adequate to satisfy its current operating plans for at least the next twelve months from the issuance of these financial statements. The Company has in the past sold equity securities through at-the-market equity offerings and in the traditional fashion of significant equity offerings. Nonetheless, management monitors the capital markets on an ongoing basis and may consider raising capital if favorable market conditions develop. If the Company’s actual results are less than projected or the Company needs to raise capital for additional liquidity, the Company may be required to do additional equity financings, reduce expenses, or enter into a strategic transaction. However, management can make no assurance that the Company will be able to raise additional capital, reduce expenses sufficiently, or enter into a strategic transaction on terms acceptable to the Company, or at all.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 5, 2023, the Company entered into a Technology License Agreement and an Asset Purchase Agreement (the “LST Agreements”) with Lightning Silicon Technology, Inc. (“LST”). Pursuant to the LST Agreements, the Company issued a license to LST for certain technology associated with our Organic Light Emitting Technology, transferred in-process development contracts with two customers and accounts receivables that the Company had previously determined were not collectible. The technology license agreement provides for Kopin to transfer certain patents to LST if LST achieves certain milestones; however upon transfer, Kopin will receive a license to the technology. To the extent LST makes improvements to the technology licensed from Kopin, Kopin will receive a license for these improvements for certain markets. Kopin is not obligated to provide any additional funding support to LST. As consideration for the transaction, the Company received <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230104__20230105__us-gaap--TypeOfArrangementAxis__custom--LSTAgreementMember__dei--LegalEntityAxis__custom--LightningSiliconTechnologyIncMember_zDZJQN99CLk8">18,000,000</span> preferred shares in LST, which the Company determined had no fair value as of the transaction date or as of September 30, 2023. While these shares represent a <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20230105__us-gaap--TypeOfArrangementAxis__custom--LSTAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LightningSiliconTechnologyIncMember_z4EcIA2zFA43">20.0</span>% equity stake in LST, they do not provide the Company with voting rights to elect LST’s Governance Board. The Company will also receive a royalty based on unit sales of products that utilize the technology licensed. Drs. John Fan, the Company’s former President, CEO and Chairman of the Board, Boryeu Tsaur, a former Executive Vice President of the Company and Hong Choi, the Company’s former Chief Technology Officer terminated their employment with the Company and became investors in and members of the management team of LST. Dr. Fan is the Founder of LST. As a result of this transaction, in 2022 the Company wrote off the two operating lease assets associated with facilities used for the development of our organic light emitting diode (OLED) products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	17000000	shares
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	11750204	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4500018	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-139719	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-111240	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11610485	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4388778	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	6193002	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5417483	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11610485	usd
CY2023Q3	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	26313174	usd
CY2022Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	20368862	usd
CY2019Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5200000	usd
CY2019Q4	us-gaap	Investments Investments	0	usd
CY2022Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	4700000	usd
CY2022Q2	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	500000	usd
CY2023Q3	us-gaap	Payments For Royalties PaymentsForRoyalties	400000	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3100000	usd
CY2023Q3	KOPN	Unrealized Loss On Equity Interest UnrealizedLossOnEquityInterest	100000	usd
	KOPN	Unrealized Loss On Equity Interest UnrealizedLossOnEquityInterest	200000	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	8143214	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	6840891	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1025000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	303000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7118214	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6537891	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3948417	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.66
	KOPN	Contract With Customer Assets Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetsLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	2059189	usd
CY2023Q3	KOPN	Percentage Of Change In Net Contract Assets Liabilities PercentageOfChangeInNetContractAssetsLiabilities	0.66	pure
CY2023Q3	KOPN	Net Contract Assets NetContractAssets	2000000.0	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	303000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	798000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	76000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1025000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	5522913	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4285757	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	2527748	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1735454	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1023831	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	405189	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	9074492	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6426400	usd
	KOPN	Contract With Customer Liability And Billings In Revenue Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityAndBillingsInRevenueCumulativeCatchUpAdjustmentToRevenueModificationOfContract	262454	usd
CY2023Q3	KOPN	Percentage Contract Liabilities And Billings In Excess Of Revenue Earned PercentageContractLiabilitiesAndBillingsInExcessOfRevenueEarned	-0.28	pure
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	23431	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	6190	usd
	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	-17241	usd
CY2023Q3	KOPN	Percentage Of Change In Contract Liabilitiesnoncurrent PercentageOfChangeInContractLiabilitiesnoncurrent	2.79	pure
CY2023Q3	KOPN	Net Contract Assets Liabilities NetContractAssetsLiabilities	5190863	usd
CY2022Q4	KOPN	Net Contract Assets Liabilities NetContractAssetsLiabilities	3131674	usd
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3948417	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2480299	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3948417	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2480299	shares
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	17000000	shares
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.26
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	41400000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1965901	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.22
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3296051	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.59
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	800842	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	2.83
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	512693	shares
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6600000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1966000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	676000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	481000	usd
CY2023Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2161000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	135500000	usd
CY2023Q3	KOPN	Operating Loss Carryforwards Unlimited OperatingLossCarryforwardsUnlimited	92900000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	5882340	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4068364	usd
	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract	1813976	usd
CY2023Q3	KOPN	Percentage Of Change In Contract Assets Current PercentageOfChangeInContractAssetsCurrent	0.45	pure
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	668046	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	930500	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	700000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3600000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	14200000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	216119	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	242833	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	648545	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	742697	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	234233	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	894227	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	637893	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	604000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	604000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	201333	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3175686	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	405088	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2770598	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35217000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	762521	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2008077	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2770598	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	741757	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0606	pure
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M9D
CY2023Q3	us-gaap	Noncurrent Assets NoncurrentAssets	4465000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	5000000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10598000	usd
CY2023Q3	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11729000	usd
CY2022Q3	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31817000	usd
	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35217000	usd
	KOPN	Percentage Of Total Revenue PercentageOfTotalRevenue	1	pure
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10598000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11729000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31817000	usd
CY2023Q3	us-gaap	Revenues Revenues	485338	usd
CY2023Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	208933	usd
CY2022Q3	us-gaap	Revenues Revenues	437825	usd
	us-gaap	Revenues Revenues	1757739	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	416988	usd
	us-gaap	Revenues Revenues	1219771	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	241632	usd
CY2023Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	154933	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	325106	usd

Files In Submission

Name	View Source	Status
kopn-20230930_pre.xml	Edgar Link	unprocessable
0001493152-23-040304-index-headers.html	Edgar Link	pending
0001493152-23-040304-index.html	Edgar Link	pending
0001493152-23-040304.txt	Edgar Link	pending
0001493152-23-040304-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
kopn-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kopn-20230930_cal.xml	Edgar Link	unprocessable
kopn-20230930_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kopn-20230930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KOPN
KOPIN CORP Stock $kopn

2023 Q4 Form 10-Q Financial Statement

#000149315223040304 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOPN KOPIN CORP Stock $kopn

2023 Q4 Form 10-Q Financial Statement

#000149315223040304 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOPN
KOPIN CORP Stock $kopn